HealthcarePress Releases

Clinical Laboratory Service Market Size to Reach US$ 290 Billion By 2030

Share This Article

According to the industry experts, The clinical laboratory service market size is projected to reach around US$ 290 billion by 2030 from USD 202.5 billion in 2021 growing at a CAGR of 5.1% from 2021 to 2030. The report contains 150+ pages with detailed analysis.

The base year for the study has been considered 2021, the historic year 2019 and 2020, the forecast period considered is from 2021 to 2030. The clinical laboratory service market is analyzed on the basis of value (US$ Million), volume (Unit), and price (US$/Unit).

The rapid growth of the research centers and increasing investments by the healthcare companies for the research and developmental activities results in reducing the complexity of current healthcare system.

Moreover, Clinical laboratory service system is registering it mark in the hospital, pharmacies, and health insurance sectors. The information based on these laboratory services are to make accurate decision while diagnose the patience. This is a major factor that boosts the growth of the global clinical laboratory service market.

The factors which augment the market are rising incidence of chronic diseases and rising demand for accurate disease diagnoses. Further, the rising adoption of innovative and automated technologies in the healthcare sector is boosting the adoption of the clinical laboratory service across the globe. The Clinical laboratory service is expected to change the way the hospitals and pharmacies operate by introducing innovative and data-centric methods and insights. Moreover,the growing penetration of cloud-based services in the healthcare sector is complementing the growth of the Clinical laboratory service market across the globe.

Download the Sample Pages of this Report for Better Understanding (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/sample/1387

Coverage of the Clinical Laboratory Service Market

Report Coverage Details
Market Size in 2021 USD 202.5 Billion
Growth Rate From 2021 to 2030 CAGR of 5.1%
Fastest Growing Market Asia Pacific
Largest Market North America
Base Year 2021
Forecast Period 2021 to 2030

Clinical Laboratory Service Market Scope

This market report studies market dynamics, status and outlook especially in North America, Europe and Asia-Pacific, Latin America, the Middle East and Africa. This research report offers scenario and forecast (revenue/volume), and categorizes the market by key players and various segment. This report also studies global market prominence, competitive landscape, market share, growth rates market dynamics such as drivers, restraints and opportunities, and distributors and sales channels.

This research study also integrates Industry Chain analysis and Porter’s Five Forces Analysis. Further, this report offers a competitive scenario that comprises collaborations, market concentration rate and expansions, mergers & acquisitions undertaken by companies.

North America dominated the market in 2020. This is attributed to the increased adoption rate of the latest technologies in the countries like US and Canada. The presence of high number of health care companies along with the various contract manufacturing organizations and contract research organizations is benefiting the market in this region. The rising investment by the private players in the research activities for the development of various drugs for the treatment of chronic disease such as cancer, leukemia, lymphoma, muscular degeneration, and diabetes has necessitated the need for the efficient management of data and hence, the demand for the Clinical laboratory service increased rapidly in the region.

Asia Pacific is expected to be the most opportunistic market during the forecast period. The rising government expenditure to develop strong healthcare infrastructure and government policies to attract FDIs is expected to play a significant role in the growth of the Clinical laboratory service market in the region. The presence of huge population and rising number of hospital admissions will foster the demand for the Clinical laboratory service systems in the Asia Pacific region, and will lead to the growth of the market during the forecast period.

The rising prevalence of chronic diseases among the population will boost the demand for the health care services, pharmacies, and health insurances. Moreover, the increasing patient awareness, evolution to pathogens, advanced in area of healthcare and biotechnology in genomics & proteomics are the driving factors for the growth of the market.

The high costs associated with the acquisition of the latest clinical laboratory service may hamper the growth of the market. Further, lack of adequate infrastructure and capital in the underdeveloped and developing nations may hamper the market growth during the forecast period.

The introduction of latest technologies such as artificial intelligence and machine learning may provide growth prospects to the market players in the upcoming future, and drive the market growth.

Based on the type, the clinical chemistry segment is the leading and the fastest-growing segment. This can be attributed to the increasing investments in the research activities for the development of life-saving drugs and diagnosis procedures to treat various chronic diseases prevalent among the global population.

Clinical Laboratory Service Market Share, By Service Provider, 2020 (%)

Based on the service provider, the hospital-based laboratories segment dominated the market. This can be attributed to the increased research activities and increased treatment of the cancer patients in the hospitals.According to the International Agency for Research on Cancer, in 2020, around 19.3 million new cancer cases and 10 million cancer deaths were reported across the globe.

Based on the application, the bioanalytical and lab chemistry services segment was the leading segment in 2020. The rising prevalence of diseases coupled with the increased number of hospital admissions has significantly contributed towards the growth of this segment in the past few years. Moreover, rising investments for the development of better and improve healthcare infrastructure is boosting the growth of the hospitals especially in the developing regions.

More Links:

Drug and Gene Delivery Market Reaches $ 815 Bn By 2030

Automated Parking System Market Size to Reach $ 3.04 Bn By 2030

Life Science Reagents Market Size to Reach $ 78 Billion By 2030

Key Players/Manufacturers

This report also provides detailed company profiles of the key market players. This research report also highlights the competitive landscape of the clinical laboratory service market and ranks noticeable companies as per their occurrence in diverse regions across the globe and crucial developments initiated by them in the market space. This research study also tracks and evaluates competitive developments, such as collaborations, partnerships, and agreements, mergers and acquisitions; novel product introductions and developments, promotion strategies and Research and Development (R&D) activities in the marketplace. The competitive profiling of these players includes business and financial overview, gross margin, production, sales, and recent developments which can aid in assessing competition in the market.

Some of the prominent players in the global clinical laboratory service market include:

  • Qiagen
  • Quest Diagnostics, Inc
  • OPKO Health, Inc
  • Abbott
  • Charles River Laboratories; International, Inc
  • Cinven
  • Arup Laboratories
  • Sonic Healthcare
  • Laboratory Corporation of America Holdings (LabCorp)
  • NeoGenomics Laboratories, Inc.

Clinical Laboratory Service Market Segments Covered

By Test Type

  • Human & Tumor Genetics
  • Clinical Chemistry
  • Medical Microbiology & Cytology
  • Other Esoteric Tests

By Service Provider

  • Hospital-Based Laboratories
  • Stand-Alone Laboratories
  • Clinic-Based Laboratories

By Application

  • Bioanalytical& Lab Chemistry Services
  • Toxicology Testing Services
  • Cell & Gene Therapy Related Services
  • Preclinical & Clinical Trial Related Services
  • Drug Discovery & Development Related Services
  • Others

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Rest of the World

Research Objective

  • To provide a comprehensive analysis of the clinical laboratory service industry and its sub-segments in the global market, thereby providing a detailed structure of the industry
  • To provide detailed insights into factors driving and restraining the growth of this global market
  • To provide a distribution chain analysis/value chain for the this market
  • To estimate the market size of the global clinical laboratory service market where 2019 would be the historical period, 2020 shall be the base year, and 2020 to 2027 will be the forecast period for the study
  • To provide strategic profiling of key companies (manufacturers and distributors) present across the globe, and comprehensively analyze their competitiveness/competitive landscape in this market
  • To analyze the global market in four main geographies, namely, North America, Europe, Asia-Pacific, and the Rest of the World
  • To provide country-wise market value analysis for various segments of the clinical laboratory service

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Clinical Laboratory Service Market 

5.1. COVID-19 Landscape: Clinical Laboratory Service Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Clinical Laboratory Service Market, By Test

8.1. Clinical Laboratory Service Market, by Test Type, 2021-2030

8.1.1. Human & Tumor Genetics

8.1.1.1. Market Revenue and Forecast (2019-2030)

8.1.2. Clinical Chemistry

8.1.2.1. Market Revenue and Forecast (2019-2030)

8.1.3. Medical Microbiology & Cytology

8.1.3.1. Market Revenue and Forecast (2019-2030)

8.1.4. Other Esoteric Tests

8.1.4.1. Market Revenue and Forecast (2019-2030)

Chapter 9. Global Clinical Laboratory Service Market, By Application

9.1. Clinical Laboratory Service Market, by Application, 2021-2030

9.1.1. Bioanalytical& Lab Chemistry Services

9.1.1.1. Market Revenue and Forecast (2019-2030)

9.1.2. Toxicology Testing Services

9.1.2.1. Market Revenue and Forecast (2019-2030)

9.1.3. Cell & Gene Therapy Related Services

9.1.3.1. Market Revenue and Forecast (2019-2030)

9.1.4. Preclinical & Clinical Trial Related Services

9.1.4.1. Market Revenue and Forecast (2019-2030)

9.1.5. Drug Discovery & Development Related Services

9.1.5.1. Market Revenue and Forecast (2019-2030)

9.1.6. Others

9.1.6.1. Market Revenue and Forecast (2019-2030)

Chapter 10. Global Clinical Laboratory Service Market, By Service Provider 

10.1. Clinical Laboratory Service Market, by Service Provider, 2021-2030

10.1.1. Hospital-Based Laboratories

10.1.1.1. Market Revenue and Forecast (2019-2030)

10.1.2. Stand-Alone Laboratories

10.1.2.1. Market Revenue and Forecast (2019-2030)

10.1.3. Clinic-Based Laboratories

10.1.3.1. Market Revenue and Forecast (2019-2030)

Chapter 11. Global Clinical Laboratory Service Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Test (2019-2030)

11.1.2. Market Revenue and Forecast, by Application (2019-2030)

11.1.3. Market Revenue and Forecast, by Service Provider (2019-2030)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Test (2019-2030)

11.1.4.2. Market Revenue and Forecast, by Application (2019-2030)

11.1.4.3. Market Revenue and Forecast, by Service Provider (2019-2030)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Test (2019-2030)

11.1.5.2. Market Revenue and Forecast, by Application (2019-2030)

11.1.5.3. Market Revenue and Forecast, by Service Provider (2019-2030)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Test (2019-2030)

11.2.2. Market Revenue and Forecast, by Application (2019-2030)

11.2.3. Market Revenue and Forecast, by Service Provider (2019-2030)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Test (2019-2030)

11.2.4.2. Market Revenue and Forecast, by Application (2019-2030)

11.2.4.3. Market Revenue and Forecast, by Service Provider (2019-2030)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Test (2019-2030)

11.2.5.2. Market Revenue and Forecast, by Application (2019-2030)

11.2.5.3. Market Revenue and Forecast, by Service Provider (2019-2030)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Test (2019-2030)

11.2.6.2. Market Revenue and Forecast, by Application (2019-2030)

11.2.6.3. Market Revenue and Forecast, by Service Provider (2019-2030)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Test (2019-2030)

11.2.7.2. Market Revenue and Forecast, by Application (2019-2030)

11.2.7.3. Market Revenue and Forecast, by Service Provider (2019-2030)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Test (2019-2030)

11.3.2. Market Revenue and Forecast, by Application (2019-2030)

11.3.3. Market Revenue and Forecast, by Service Provider (2019-2030)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Test (2019-2030)

11.3.4.2. Market Revenue and Forecast, by Application (2019-2030)

11.3.4.3. Market Revenue and Forecast, by Service Provider (2019-2030)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Test (2019-2030)

11.3.5.2. Market Revenue and Forecast, by Application (2019-2030)

11.3.5.3. Market Revenue and Forecast, by Service Provider (2019-2030)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Test (2019-2030)

11.3.6.2. Market Revenue and Forecast, by Application (2019-2030)

11.3.6.3. Market Revenue and Forecast, by Service Provider (2019-2030)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Test (2019-2030)

11.3.7.2. Market Revenue and Forecast, by Application (2019-2030)

11.3.7.3. Market Revenue and Forecast, by Service Provider (2019-2030)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Test (2019-2030)

11.4.2. Market Revenue and Forecast, by Application (2019-2030)

11.4.3. Market Revenue and Forecast, by Service Provider (2019-2030)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Test (2019-2030)

11.4.4.2. Market Revenue and Forecast, by Application (2019-2030)

11.4.4.3. Market Revenue and Forecast, by Service Provider (2019-2030)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Test (2019-2030)

11.4.5.2. Market Revenue and Forecast, by Application (2019-2030)

11.4.5.3. Market Revenue and Forecast, by Service Provider (2019-2030)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Test (2019-2030)

11.4.6.2. Market Revenue and Forecast, by Application (2019-2030)

11.4.6.3. Market Revenue and Forecast, by Service Provider (2019-2030)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Test (2019-2030)

11.4.7.2. Market Revenue and Forecast, by Application (2019-2030)

11.4.7.3. Market Revenue and Forecast, by Service Provider (2019-2030)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Test (2019-2030)

11.5.2. Market Revenue and Forecast, by Application (2019-2030)

11.5.3. Market Revenue and Forecast, by Service Provider (2019-2030)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Test (2019-2030)

11.5.4.2. Market Revenue and Forecast, by Application (2019-2030)

11.5.4.3. Market Revenue and Forecast, by Service Provider (2019-2030)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Test (2019-2030)

11.5.5.2. Market Revenue and Forecast, by Application (2019-2030)

11.5.5.3. Market Revenue and Forecast, by Service Provider (2019-2030)

Chapter 12. Company Profiles

12.1. Qiagen

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Quest Diagnostics, Inc

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. OPKO Health, Inc

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Abbott

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Charles River Laboratories; International, Inc

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Cinven

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Arup Laboratories

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Sonic Healthcare

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Laboratory Corporation of America Holdings (LabCorp)

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. NeoGenomics Laboratories, Inc.

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Why Buy this Report?

The purpose of Precedence Research’s clinical laboratory service market study is to provide stakeholders with a detailed picture of potential barriers and untapped opportunities. The report contains exclusive information to assist businesses in making informed decisions about how to maintain growth throughout the assessment period.

Buy Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1387

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://precedenceresearchnews.wordpress.com

Follow us on LinkedIn | Twitter | Facebook

Frequently Asked Questions

[WPSM_AC id=6550]
Show More

Market Stats News

Market Stats News is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services, we aim at connecting an organization’s goal with lucrative prospects globally.

Related Articles

Back to top button